You are not logged in. | Log in
In Progress
Clinical

Node Negative, 61-, T1-2

Purpose

Recently, a 76-gene prognostic signature able to predict distant metastases in lymph node–negative (N-) breast cancer patients was reported. The aims of this study conducted by TRANSBIG were to independently validate these results and to compare the outcome with clinical risk assessment.

Hypothesis

Dataset of microarray experiments from primary breast tumors used to validate the 76-gene signature (VERIDEX). No replicate, no reference sample.

Experimental Design

Patients were younger than the age of 61 years (median age, 47 years) and had node-negative, T1-T2 (?5 cm) tumors. Patients in this series had been diagnosed between 1980 and 1998 (median follow-up, 13.6 years) and had been seen at six centers: Institut Gustave Roussy, Villejuif, France (IGR); Karolinska Institute, Stockholm and Uppsala University Hospital, Uppsala, Sweden (KI); Centre René Huguenin, Saint-Cloud, France (CRH); Guy's Hospital, London, United Kingdom (GH); and John Radcliffe Hospital, Oxford, United Kingdom (JRH). Patients with previous malignancies (except basal cell carcinoma) and bilateral synchronous breast tumors were excluded. The corresponding paraffin-embedded tumor samples of these patients were sent to the Department of Pathology at the European Institute of Oncology, Milan, Italy, where ER status (using immunohistochemistry) and histologic grade (using the Elston and Ellis method) were determined by the same pathologist, blinded to the clinical and genomic data. The clinical centers were also visited by two independent auditors who carried out source data verification of all data in the validation series. The validation protocol was finalized in September 2005, and all institutional ethics committees approved the use of the tumor materials for the purposes described in this study.

Experimental Variables

--

Controls

--

Methods

Frozen samples were sent from the clinical centers to the Netherlands Cancer Institute, Amsterdam, where RNA had been extracted for the previous TRANSBIG validation study of the 70-gene profile on the Agilent platform (7), except for the samples from Centre René Huguenin, for which RNA was sent directly to Amsterdam. To carry out the present study, RNAs were then shipped to the Jules Bordet Institute to perform the microarray analyses using the Affymetrix U133a GeneChip blinded to clinical data and independent of Veridex. The quality of the RNA obtained from each tumor sample was assessed via the RNA profile generated by the Agilent bioanalyzer. RNA amplification, hybridization, and image scanning were done according to standard Affymetrix protocols. Expression values for each gene were calculated using Affymetrix GeneChip analysis software MAS 5.0. For chip normalization, probe sets were scaled to a target intensity of 600, and scale mask filters were not selected. Chips with signal to noise ratio < 24 were excluded. Each probe set was considered as a separate gene.

Additional Information

Desmedt, Christine, Fanny Piette, Sherene Loi, Yixin Wang, Françoise Lallemand, Benjamin Haibe-Kains, Giuseppe Viale, et al. “Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series.” Clinical Cancer Research 13, no. 11 (June 1, 2007): 3207–14. doi:10.1158/1078-0432.CCR-06-2765.

Microarray
Affymetrix HG-U133A
198 Samples Loaded: 198
Human (Homo sapiens)
Uppsala University Hospital , Uppsala, Sweden , Centre Rene´ Huguenin, Saint-Cloud, France , Breast Cancer Tissue , Nagalla 2013 , Guys Hospital, London, UK , Institut Gustave Roussy, Villejuif, France , John Radcliffe Hospital, Oxford, UK , Karolinska Hospital, Stockholm, Sweden
LN- Breast Cancer
Sample Set Spreadsheet
Please log in in order to upload files.
Samples Preview
Sample ID series NPI IMS IBS IDS
GSM177885 GUY 4.6 Basal IBE PID
GSM177886 GUY 4.6 LumB IBE FID
GSM177887 GUY 4.5 ClaudinLow IBD WID
GSM177888 GUY 4.36 LumB IBE FID
GSM177889 GUY 3.6 LumB IBD PID
Please log in in order to upload files.
File
GSE7390_appended.meta.data_v2.csv
Sample Set Spreadsheet
Log2 Transformed
  •   |  View in GXB »
Clinical Datasource
Links

Samples Viewer / Editor

All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.

Sample ID Series NPI IMS IBS IDS ICR Array Sample ID Sample Title DMFS 10Y EVENT DMFS 10Y TIME Disease Free Survival Event Distant Met Free Survival Event Age At Initial Pathologic Diagnosis Lymph Node Status ER Status PR Status Histology Differentiation Grade Tumor Size Cm Pathology T Stage Disease Free Survival Days Distant Met Free Survival Days Histologic Diagnosis Type Treatment Vital Status Overal Survival Angio Invasion Indicator Lymphocyte Infiltration Cell File Risk AOL Indicator Risk NPI Indicator Risk SG Risk Veridex Indicator Distant Metastasis Event Survival Time Days Time To Distant Metastasis Days
GSM177885
GUY
4.6
Basal
IBE
PID
ICR1
4002
VDXGUYU_4002
DistantMetastasis
1.98
Recurred/Progressed
DistantMetastasis
57
LN-
ER-
NA
G3
3
T2
723
723
1
0
dead
62.7
1
2
10-4002_GUYA.CEL.gz
1
2
2
Poor
1
937
723
GSM177886
GUY
4.6
LumB
IBE
FID
ICR3
4008
VDXGUYU_4008
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
57
LN-
ER+
NA
G3
3
T2
183
6591
2
0
alive
69
1
3
26-4008_GUYA.CEL.gz
1
2
2
Poor
0
6591
6591
GSM177887
GUY
4.5
ClaudinLow
IBD
WID
ICR2
4011
VDXGUYU_4011
DistantMetastasis
1.44
Recurred/Progressed
DistantMetastasis
48
LN-
ER-
NA
G3
2.5
T2
524
524
1
1
dead
66.2
0
2
6-4011_GUYA.CEL.gz
1
2
2
Poor
1
922
524
GSM177888
GUY
4.36
LumB
IBE
FID
ICR4
4014
VDXGUYU_4014
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasis
42
LN-
ER+
NA
G3
1.8
T1c
2192
6255
1
0
dead
84.9
1
3
9-4014_GUYA.CEL.gz
1
2
2
Poor
0
6255
6255
GSM177889
GUY
3.6
LumB
IBD
PID
ICR1
4022
VDXGUYU_4022
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasis
46
LN-
ER+
NA
G2
3
T2
3822
3822
1
0
dead
80.2
1
2
219-4022_GUYA.CEL.gz
1
2
2
Poor
1
4133
3822
GSM177890
GUY
3.4
LumA
IBD
FID
ICR3
4033
VDXGUYU_4033
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
58
LN-
ER+
NA
G2
2
T1c
6507
6507
2
0
alive
83.1
1
2
17-4033_GUYA.CEL.gz
1
2
2
Good
0
6507
6507
GSM177891
GUY
4.4
Basal
IBE
WID
ICR3
4034
VDXGUYU_4034
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
44
LN-
ER-
NA
G3
2
T1c
709
5947
1
1
alive
80.6
1
3
16-4034_GUYA.CEL.gz
1
2
2
Poor
0
5947
5947
GSM177892
GUY
2.5
LumA
IBD
FID
ICR3
4036
VDXGUYU_4036
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasis
58
LN-
ER+
NA
G1
2.5
T2
5816
5816
2
1
dead
82.1
1
2
24-4036_GUYA.CEL.gz
1
1
2
Good
0
5816
5816
GSM177893
GUY
4.6
LumA
IBD
PID
ICR2
4040
VDXGUYU_4040
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
47
LN-
ER+
NA
G3
3
T2
6007
6007
2
0
alive
73.2
2
NA
13-4040_GUYA.CEL.gz
1
2
2
Poor
0
6007
6007
GSM177894
GUY
3.5
Basal
IBE
WID
ICR3
4041
VDXGUYU_4041
DistantMetastasis
3.38
Recurred/Progressed
DistantMetastasis
38
LN-
ER+
NA
G2
2.5
T2
422
1233
2
0
dead
81.5
2
3
5-4041_GUYA.CEL.gz
1
2
2
Poor
1
1484
1233
GSM177895
GUY
4.4
LumB
IBE
WID
ICR3
4043
VDXGUYU_4043
DistantMetastasis
3.11
Recurred/Progressed
DistantMetastasis
59
LN-
ER+
NA
G3
2
T1c
1136
1136
1
1
dead
77.8
1
2
2-4043_GUYA.CEL.gz
1
2
2
Poor
1
1911
1136
GSM177896
GUY
2.16
LumA
IBD
PID
ICR1
4044
VDXGUYU_4044
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
50
LN-
ER+
NA
G1
0.8
T1b
5984
5984
1
0
alive
94.3
1
1
3-4044_GUYA.CEL.gz
0
1
1
Good
0
5984
5984
GSM177897
GUY
4.9
Basal
IBE
WID
ICR4
4045
VDXGUYU_4045
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
46
LN-
ER-
NA
G3
4.5
T2
6249
6249
1
0
alive
62.7
1
3
22-4045_GUYA.CEL.gz
1
2
2
Poor
0
6249
6249
GSM177898
GUY
3.4
Normal
IBE
NA
ICR3
4046
VDXGUYU_4046
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasis
57
LN-
ER-
NA
G2
2
T1c
2841
4066
1
0
dead
78.3
1
2
19-4046_GUYA.CEL.gz
1
2
2
Good
1
4372
4066
GSM177899
GUY
4.5
Basal
IBE
FID
ICR4
4049
VDXGUYU_4049
DistantMetastasis
1.89
Recurred/Progressed
DistantMetastasis
33
LN-
ER-
NA
G3
2.5
T2
458
690
1
0
dead
68.1
3
3
20-4049_GUYA.CEL.gz
1
2
2
Good
1
977
690
GSM177900
GUY
4.4
LumA
IBD
PID
ICR2
4052
VDXGUYU_4052
DistantMetastasis
2.72
Recurred/Progressed
DistantMetastasis
42
LN-
ER+
NA
G3
2
T1c
994
994
2
0
dead
84.9
NA
1
197-4052_GUYA.CEL.gz
1
2
2
Poor
1
3830
994
GSM177901
GUY
4.4
Basal
IBE
PID
ICR3
4054
VDXGUYU_4054
DistantMetastasis
1.19
Recurred/Progressed
DistantMetastasis
38
LN-
ER-
NA
G3
2
T1c
282
434
1
0
dead
81.5
2
2
7-4054_GUYA.CEL.gz
1
2
2
Poor
1
667
434
GSM177902
GUY
3.5
Her2
IBD
PID
ICR2
4056
VDXGUYU_4056
DistantMetastasis
4.78
Recurred/Progressed
DistantMetastasis
55
LN-
ER-
NA
G2
2.5
T2
548
1743
1
1
dead
65.5
3
2
213-4056_GUYA.CEL.gz
1
2
2
Poor
1
2129
1743
GSM177903
GUY
3.5
Her2
IBD
WID
ICR4
4060
VDXGUYU_4060
DistantMetastasis
7.84
Recurred/Progressed
DistantMetastasis
57
LN-
ER-
NA
G2
2.5
T2
1820
2863
1
0
dead
64.5
1
3
8-4060_GUYA.CEL.gz
1
2
2
Poor
1
3590
2863
GSM177904
GUY
3.5
LumA
IBD
PID
ICR2
4061
VDXGUYU_4061
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
46
LN-
ER+
NA
G2
2.5
T2
5693
5693
1
0
alive
80.2
3
2
209-4061_GUYA.CEL.gz
1
2
2
Poor
0
5693
5693
GSM177905
GUY
3.4
Her2
IBD
PID
ICR2
4062
VDXGUYU_4062
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
50
LN-
ER+
NA
G2
2
T1c
5823
5823
1
0
alive
87.6
2
3
228-4062_GUYA.CEL.gz
1
2
2
Poor
0
5823
5823
GSM177906
GUY
4.4
Basal
IBE
PID
ICR1
4067
VDXGUYU_4067
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
46
LN-
ER-
NA
G3
2
T1c
5785
5785
1
1
alive
80.2
1
3
207-4067_GUYA.CEL.gz
1
2
2
Poor
0
5785
5785
GSM177907
GUY
3.5
Normal
IBE
NA
ICR3
4072
VDXGUYU_4072
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
46
LN-
ER+
NA
G2
2.5
T2
5598
5661
1
0
alive
80.2
2
2
27-4072_GUYA.CEL.gz
1
2
2
Poor
0
5661
5661
GSM177908
GUY
3.3
LumB
IBE
PID
ICR1
4073
VDXGUYU_4073
DistantMetastasis
7.97
Recurred/Progressed
DistantMetastasis
51
LN-
ER+
NA
G2
1.5
T1c
2909
2909
1
0
dead
87.2
1
2
12-4073_GUYA.CEL.gz
1
1
2
Poor
0
2909
2909
GSM177909
GUY
4.5
Basal
IBE
PID
ICR4
4074
VDXGUYU_4074
DistantMetastasis
3.21
Recurred/Progressed
DistantMetastasis
58
LN-
ER-
NA
G3
2.5
T2
121
1171
1
1
dead
62.1
3
3
15-4074_GUYA.CEL.gz
1
2
2
Poor
1
1674
1171
GSM177910
GUY
2.52
LumA
IBD
PID
ICR1
4075
VDXGUYU_4075
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
59
LN-
ER+
NA
G1
2.6
T2
5110
5110
3
0
alive
81.4
1
2
23-4075_GUYA.CEL.gz
1
1
2
Good
0
5110
5110
GSM177911
GUY
3.12
LumA
IBD
WID
ICR1
4076
VDXGUYU_4076
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
49
LN-
ER+
NA
G2
0.6
T1b
5533
5533
1
1
alive
92.8
1
1
11-4076_GUYA.CEL.gz
0
1
2
Good
0
5533
5533
GSM177912
GUY
2.5
Normal
IBE
NA
ICR1
4080
VDXGUYU_4080
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
43
LN-
ER+
NA
G1
2.5
T2
1429
5571
1
0
alive
88.7
1
1
199-4080_GUYA.CEL.gz
0
1
2
Good
0
5571
5571
GSM177913
GUY
4.4
Basal
IBE
WID
ICR3
4081
VDXGUYU_4081
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
47
LN-
ER-
NA
G3
2
T1c
5519
5519
1
1
alive
80
1
3
25-4081_GUYA.CEL.gz
1
2
2
Poor
0
5519
5519
GSM177914
GUY
4.34
LumA
IBD
FID
ICR4
4087
VDXGUYU_4087
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
37
LN-
ER+
NA
G3
1.7
T1c
5379
5379
1
1
alive
85.6
2
3
18-4087_GUYA.CEL.gz
1
2
2
Good
0
5379
5379
GSM177915
GUY
4.8
Her2
IBD
FID
ICR4
4088
VDXGUYU_4088
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
48
LN-
ER+
NA
G3
4
T2
4675
4675
1
0
alive
65.2
1
3
14-4088_GUYA.CEL.gz
1
2
2
Good
0
4675
4675
GSM177916
GUY
3.38
LumB
IBE
PID
ICR2
4096
VDXGUYU_4096
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
47
LN-
ER+
NA
G2
1.9
T1c
1666
4652
1
0
alive
88.6
1
2
189-4096_GUYA.CEL.gz
0
2
2
Poor
0
4652
4652
GSM177917
GUY
3.5
LumA
IBD
PID
ICR1
4097
VDXGUYU_4097
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
46
LN-
ER+
NA
G2
2.5
T2
4227
4227
1
0
alive
80.2
1
2
200-4097_GUYA.CEL.gz
1
2
2
Poor
0
4227
4227
GSM177918
GUY
4.4
Her2
IBD
FID
ICR3
4098
VDXGUYU_4098
DistantMetastasis
2.49
Recurred/Progressed
DistantMetastasis
48
LN-
ER-
NA
G3
2
T1c
316
910
1
0
dead
79.7
2
2
4-4098_GUYA.CEL.gz
1
2
2
Poor
1
1530
910
GSM177919
GUY
3.38
LumA
IBD
PID
ICR1
4099
VDXGUYU_4099
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
58
LN-
ER+
NA
G2
1.9
T1c
4472
4472
1
0
alive
83.1
1
2
21-4099_GUYA.CEL.gz
1
2
2
Good
0
4472
4472
GSM177920
GUY
4.4
LumB
IBE
PID
ICR1
4105
VDXGUYU_4105
DistantMetastasis
3.3
Recurred/Progressed
DistantMetastasis
34
LN-
ER+
NA
G3
2
T1c
350
1206
1
0
dead
79.9
1
1
1-4105_GUYA.CEL.gz
1
2
2
Poor
1
1275
1206
GSM177921
IGR
3.9
LumA
IBD
WID
ICR2
166154
VDXIGRU_166154
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
30
LN-
ER+
NA
G2
4.5
T2
5632
7057
1
1
alive
65.3
1
1
233-166154_IGRA.CEL.gz
1
2
2
Poor
0
7057
7057
GSM177922
IGR
3.6
LumA
IBD
FID
ICR3
171150
VDXIGRU_171150
DistantMetastasisFree
2.62
DiseaseFree
DistantMetastasisFree
35
LN-
ER+
NA
G2
3
T2
958
958
1
1
alive
81.8
1
2
68-171150_IGRA.CEL.gz
1
2
2
Good
0
958
958
GSM177923
IGR
4.52
ClaudinLow
IBD
FID
ICR4
171260
VDXIGRU_171260
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
56
LN-
ER-
NA
G3
2.6
T2
5359
5359
1
0
alive
63.2
1
2
30-171260_IGRA.CEL.gz
1
2
2
Good
0
5359
5359
GSM177924
IGR
3.64
LumA
IBD
PID
ICR1
171558
VDXIGRU_171558
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
35
LN-
ER-
NA
G2
3.2
T2
5945
5945
8
1
alive
66.1
1
1
47-171558_IGRA.CEL.gz
1
2
2
Good
0
5945
5945
GSM177925
IGR
4.54
ClaudinLow
IBD
FID
ICR3
171620
VDXIGRU_171620
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
52
LN-
ER-
NA
G3
2.7
T2
5651
5651
1
1
alive
64.9
1
1
178-171620_IGRA.CEL.gz
1
2
2
Poor
0
5651
5651
GSM177926
IGR
4.6
LumB
IBE
PID
ICR1
172086
VDXIGRU_172086
DistantMetastasis
1.45
Recurred/Progressed
DistantMetastasis
47
LN-
ER+
NA
G3
3
T2
528
528
1
0
dead
73.2
1
2
192-172086_IGRA.CEL.gz
1
2
2
Poor
1
6036
528
GSM177927
IGR
4.32
Her2
IBD
WID
ICR2
211980
VDXIGRU_211980
DistantMetastasis
2.18
Recurred/Progressed
DistantMetastasis
42
LN-
ER-
NA
G3
1.6
T1c
408
796
1
0
dead
81
1
2
70-211980_IGRA.CEL.gz
1
2
2
Poor
1
1436
796
GSM177928
IGR
3.34
LumA
IBD
PID
ICR2
214603
VDXIGRU_214603
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
54
LN-
ER+
NA
G2
1.7
T1c
5685
5685
1
0
alive
85.7
1
2
31-214603_IGRA.CEL.gz
1
2
2
Good
0
5685
5685
GSM177929
IGR
4.5
LumB
IBE
WID
ICR4
216806
VDXIGRU_216806
DistantMetastasis
2.8
Recurred/Progressed
DistantMetastasis
42
LN-
ER+
NA
G3
2.5
T2
1023
1023
1
0
dead
74.2
1
1
33-216806_IGRA.CEL.gz
1
2
2
Poor
1
1754
1023
GSM177930
IGR
3.5
LumA
IBD
WID
ICR2
216939
VDXIGRU_216939
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
50
LN-
ER+
NA
G2
2.5
T2
4791
4791
1
0
alive
79
1
2
58-216939_IGRA.CEL.gz
1
2
2
Good
0
4791
4791
GSM177931
IGR
2.6
LumA
IBD
PID
ICR1
217320
VDXIGRU_217320
DistantMetastasisFree
3.33
DiseaseFree
DistantMetastasisFree
42
LN-
ER+
NA
G1
3
T2
1215
1215
1
1
alive
88.9
1
2
36-217320_IGRA.CEL.gz
0
1
2
Poor
0
1215
1215
GSM177932
IGR
2.7
LumA
IBD
PID
ICR1
219139
VDXIGRU_219139
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
38
LN-
ER+
NA
G1
3.5
T2
3779
3779
1
0
alive
84.5
1
2
202-219139_IGRA.CEL.gz
1
1
2
Poor
0
3779
3779
GSM177933
IGR
4.5
LumB
IBD
PID
ICR2
219468
VDXIGRU_219468
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
37
LN-
ER+
NA
G3
2.5
T2
5306
5306
1
0
alive
74.7
1
1
61-219468_IGRA.CEL.gz
1
2
2
Poor
0
5306
5306
GSM177934
IGR
4.6
LumB
IBE
WID
ICR4
219490
VDXIGRU_219490
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
44
LN-
ER+
NA
G3
3
T2
5678
5678
1
1
alive
73.8
1
3
52-219490_IGRA.CEL.gz
1
2
2
Poor
0
5678
5678
GSM177935
IGR
4.62
Basal
IBE
WID
ICR3
219587
VDXIGRU_219587
DistantMetastasis
1.15
Recurred/Progressed
DistantMetastasis
37
LN-
ER-
NA
G3
3.1
T2
421
421
1
0
dead
63.9
1
2
240-219587_IGRA.CEL.gz
1
2
2
Poor
1
794
421
GSM177936
IGR
3.3
LumA
IBD
FID
ICR3
219863
VDXIGRU_219863
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
51
LN-
ER+
NA
G2
1.5
T1c
840
5612
1
0
alive
87.2
1
2
35-219863_IGRA.CEL.gz
1
1
2
Good
0
5612
5612
GSM177937
IGR
4.8
ClaudinLow
IBD
FID
ICR4
219873
VDXIGRU_219873
DistantMetastasis
8.55
Recurred/Progressed
DistantMetastasis
53
LN-
ER-
NA
G3
4
T2
3121
3121
1
1
alive
60.8
NA
NA
37-219873_IGRA.CEL.gz
1
2
2
Good
1
3326
3121
GSM177938
IGR
2.5
LumA
IBD
WID
ICR1
245392
VDXIGRU_245392
DistantMetastasisFree
3.02
DiseaseFree
DistantMetastasisFree
49
LN-
ER+
NA
G1
2.5
T2
1104
1104
7
0
alive
87
1
2
39-245392_IGRA.CEL.gz
1
1
2
Good
0
1104
1104
GSM177939
IGR
4.6
Her2
IBE
FID
ICR3
245596
VDXIGRU_245596
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
43
LN-
ER-
NA
G3
3
T2
4691
4691
1
1
alive
67.1
1
2
208-245596_IGRA.CEL.gz
1
2
2
Good
0
4691
4691
GSM177940
IGR
3.44
LumA
IBD
PID
ICR2
246047
VDXIGRU_246047
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
39
LN-
ER+
NA
G2
2.2
T2
1609
5238
1
0
alive
81.4
2
2
42-246047_IGRA.CEL.gz
1
2
2
Poor
0
5238
5238
GSM177941
IGR
3.4
LumA
IBD
PID
ICR1
246166
VDXIGRU_246166
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
47
LN-
ER+
NA
G2
2
T1c
5101
5101
1
0
alive
88.6
1
1
239-246166_IGRA.CEL.gz
0
2
2
Poor
0
5101
5101
GSM177942
IGR
4.38
Her2
IBE
FID
ICR4
246381
VDXIGRU_246381
DistantMetastasisFree
7.7
DiseaseFree
DistantMetastasisFree
42
LN-
ER+
NA
G3
1.9
T1c
2809
2809
1
0
alive
84.9
1
2
45-246381_IGRA.CEL.gz
1
2
2
Poor
0
2809
2809
GSM177943
IGR
3.24
Basal
IBE
WID
ICR3
246560
VDXIGRU_246560
DistantMetastasisFree
9.03
DiseaseFree
DistantMetastasisFree
39
LN-
ER-
NA
G2
1.2
T1c
3296
3296
1
0
alive
84.4
1
2
185-246560_IGRA.CEL.gz
1
1
2
Poor
0
3296
3296
GSM177944
IGR
3.6
ClaudinLow
IBD
PID
ICR1
246821
VDXIGRU_246821
DistantMetastasisFree
9.74
Recurred/Progressed
DistantMetastasisFree
52
LN-
ER+
NA
G2
3
T2
546
3555
1
1
alive
78.1
1
2
193-246821_IGRA.CEL.gz
1
2
2
Poor
0
3555
3555
GSM177945
IGR
3.3
LumB
IBD
PID
ICR3
246919
VDXIGRU_246919
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
50
LN-
ER+
NA
G2
1.5
T1c
3525
5433
1
0
alive
87.6
2
2
217-246919_IGRA.CEL.gz
1
1
2
Poor
0
5433
5433
GSM177946
IGR
4.44
Her2
IBE
PID
ICR1
247000
VDXIGRU_247000
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
36
LN-
ER+
NA
G3
2.2
T2
854
5228
1
0
alive
74.8
2
1
40-247000_IGRA.CEL.gz
1
2
2
Poor
0
5228
5228
GSM177947
IGR
3.5
LumA
IBD
PID
ICR2
247243
VDXIGRU_247243
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
45
LN-
ER+
NA
G2
2.5
T2
1813
5316
1
0
alive
80.4
NA
NA
64-247243_IGRA.CEL.gz
1
2
2
Poor
0
5316
5316
GSM177948
IGR
2.34
LumA
IBD
PID
ICR2
247401
VDXIGRU_247401
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
50
LN-
ER+
NA
G1
1.7
T1c
4925
4925
1
0
alive
92.4
1
2
51-247401_IGRA.CEL.gz
0
1
1
Good
0
4925
4925
GSM177949
IGR
4.46
NA
IBE
NA
ICR2
254031
VDXIGRU_254031
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
39
LN-
ER+
NA
G3
2.3
T2
3853
5012
1
0
alive
74.5
NA
NA
54-254031_IGRA.CEL.gz
1
2
2
Poor
0
5012
5012
GSM177950
IGR
2.6
LumA
IBD
PID
ICR1
254485
VDXIGRU_254485
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
44
LN-
ER+
NA
G1
3
T2
4642
4642
1
0
alive
88.4
1
1
179-254485_IGRA.CEL.gz
0
1
2
Good
0
4642
4642
GSM177951
IGR
2.26
Normal
IBE
NA
ICR3
255160
VDXIGRU_255160
DistantMetastasisFree
9.07
DiseaseFree
DistantMetastasisFree
50
LN-
ER+
NA
G1
1.3
T1c
3311
3311
1
0
alive
92.4
1
1
44-255160_IGRA.CEL.gz
0
1
1
Good
0
3311
3311
GSM177952
IGR
3.36
ClaudinLow
IBD
PID
ICR1
255627
VDXIGRU_255627
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
51
LN-
ER+
NA
G2
1.8
T1c
4863
4863
1
0
alive
87.2
1
2
222-255627_IGRA.CEL.gz
1
2
2
Poor
0
4863
4863
GSM177953
IGR
2.4
LumB
IBD
PID
ICR2
256209
VDXIGRU_256209
DistantMetastasis
4.97
Recurred/Progressed
DistantMetastasis
49
LN-
ER+
NA
G1
2
T1c
1780
1815
1
1
dead
92.8
1
1
227-256209_IGRA.CEL.gz
0
1
1
Poor
1
3347
1815
GSM177954
IGR
3.4
ClaudinLow
IBD
PID
ICR3
256734
VDXIGRU_256734
DistantMetastasis
2.2
Recurred/Progressed
DistantMetastasis
37
LN-
ER-
NA
G2
2
T1c
803
803
1
0
dead
84.6
1
1
220-256734_IGRA.CEL.gz
1
2
2
Poor
1
1049
803
GSM177955
IGR
3.36
LumA
IBD
WID
ICR2
256940
VDXIGRU_256940
DistantMetastasisFree
5.77
DiseaseFree
DistantMetastasisFree
51
LN-
ER+
NA
G2
1.8
T1c
2105
2105
1
0
alive
87.2
1
2
55-256940_IGRA.CEL.gz
1
2
2
Poor
0
2105
2105
GSM177956
IGR
4.4
ClaudinLow
IBD
FID
ICR3
256975
VDXIGRU_256975
DistantMetastasis
1.45
Recurred/Progressed
DistantMetastasis
40
LN-
ER-
NA
G3
2
T1c
530
530
1
0
dead
81.3
2
1
183-256975_IGRA.CEL.gz
1
2
2
Poor
1
929
530
GSM177957
IGR
2.4
LumA
IBD
WID
ICR2
271448
VDXIGRU_271448
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
44
LN-
ER+
NA
G1
2
T1c
4830
4830
1
1
alive
94.3
1
2
187-271448_IGRA.CEL.gz
0
1
1
Poor
0
4830
4830
GSM177958
IGR
4.4
LumB
IBE
WID
ICR3
271982
VDXIGRU_271982
DistantMetastasis
4.72
Recurred/Progressed
DistantMetastasis
49
LN-
ER+
NA
G3
2
T1c
1721
1721
1
0
dead
83.2
1
1
231-271982_IGRA.CEL.gz
1
2
2
Poor
1
2148
1721
GSM177959
IGR
2.3
Her2
IBD
PID
ICR3
272219
VDXIGRU_272219
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
53
LN-
ER+
NA
G1
1.5
T1c
4720
4720
7
0
alive
90.9
1
1
214-272219_IGRA.CEL.gz
0
1
1
Poor
0
4720
4720
GSM177960
IGR
3.58
LumB
IBE
PID
ICR2
272823
VDXIGRU_272823
DistantMetastasis
3.45
Recurred/Progressed
DistantMetastasis
44
LN-
ER+
NA
G2
2.9
T2
1259
1259
1
0
dead
80.6
1
1
59-272823_IGRA.CEL.gz
1
2
2
Poor
1
2453
1259
GSM177961
IGR
3.46
Normal
IBE
NA
ICR1
280328
VDXIGRU_280328
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasis
48
LN-
ER+
NA
G2
2.3
T2
3976
3976
1
1
alive
79.6
NA
NA
43-280328_IGRA.CEL.gz
1
2
2
Good
1
4438
3976
GSM177962
IGR
3.5
LumA
IBD
WID
ICR2
280352
VDXIGRU_280352
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasis
57
LN-
ER+
NA
G2
2.5
T2
3331
4050
1
0
alive
75.5
NA
NA
56-280352_IGRA.CEL.gz
1
2
2
Good
1
4469
4050
GSM177963
IGR
4.6
ClaudinLow
IBD
WID
ICR3
280775
VDXIGRU_280775
DistantMetastasisFree
4.77
DiseaseFree
DistantMetastasisFree
45
LN-
ER+
NA
G3
3
T2
1740
1740
1
1
alive
73.6
1
3
66-280775_IGRA.CEL.gz
1
2
2
Poor
0
1740
1740
GSM177964
IGR
2.4
LumA
IBD
PID
ICR1
287897
VDXIGRU_287897
DistantMetastasis
9.88
Recurred/Progressed
DistantMetastasis
44
LN-
ER+
NA
G1
2
T1c
3218
3608
1
0
dead
94.3
1
2
48-287897_IGRA.CEL.gz
0
1
1
Good
0
3608
3608
GSM177965
IGR
3.3
LumA
IBD
PID
ICR1
306818
VDXIGRU_306818
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
39
LN-
ER+
NA
G2
1.5
T1c
2536
3900
1
0
alive
90.3
2
2
63-306818_IGRA.CEL.gz
0
1
2
Good
0
3900
3900
GSM177966
IGR
4.6
ClaudinLow
IBD
PID
ICR3
307251
VDXIGRU_307251
DistantMetastasisFree
4.26
DiseaseFree
DistantMetastasisFree
40
LN-
ER-
NA
G3
3
T2
1554
1554
1
0
alive
67.6
1
1
225-307251_IGRA.CEL.gz
1
2
2
Poor
0
1554
1554
GSM177967
IGR
4.4
LumA
IBD
PID
ICR1
307327
VDXIGRU_307327
DistantMetastasisFree
9.71
DiseaseFree
DistantMetastasisFree
38
LN-
ER+
NA
G3
2
T1c
3544
3544
1
0
alive
85.5
1
2
29-307327_IGRA.CEL.gz
1
2
2
Good
0
3544
3544
GSM177968
IGR
2.52
Basal
IBE
FID
ICR3
307506
VDXIGRU_307506
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
45
LN-
ER+
NA
G1
2.6
T2
3721
3721
1
0
alive
88.2
1
1
60-307506_IGRA.CEL.gz
0
1
2
Poor
0
3721
3721
GSM177969
IGR
3.52
LumA
IBD
WID
ICR2
307829
VDXIGRU_307829
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
43
LN-
ER+
NA
G2
2.6
T2
3771
3771
1
0
alive
80.8
3
2
28-307829_IGRA.CEL.gz
1
2
2
Poor
0
3771
3771
GSM177970
IGR
4.3
Basal
IBE
FID
ICR4
314827
VDXIGRU_314827
DistantMetastasisFree
9.02
DiseaseFree
DistantMetastasisFree
47
LN-
ER-
NA
G3
1.5
T1c
3293
3293
6
0
alive
80
1
1
57-314827_IGRA.CEL.gz
1
2
2
Poor
0
3293
3293
GSM177971
JRH
3.36
NA
IBE
NA
ICR4
37
VDXOXFU_37
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
38
LN-
ER-
NA
G2
1.8
T1c
3093
3800
1
0
alive
84.5
1
NA
76-37_OXFA.CEL.gz
1
2
2
Poor
0
3800
3800
GSM177972
JRH
3.4
Normal
IBE
NA
ICR2
57
VDXOXFU_57
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasis
43
LN-
ER-
NA
G2
2
T1c
4396
4415
1
1
alive
83.8
NA
NA
108-57_OXFA.CEL.gz
1
2
2
Poor
1
4455
4415
GSM177973
JRH
4.62
LumB
IBE
PID
ICR2
104
VDXOXFU_104
DistantMetastasis
1.78
Recurred/Progressed
DistantMetastasis
60
LN-
ER+
NA
G3
3.1
T2
649
649
3
0
dead
59.9
NA
NA
74-104_OXFA.CEL.gz
1
2
2
Poor
1
1029
649
GSM177974
JRH
3.4
NA
IBE
NA
ICR4
157
VDXOXFU_157
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
42
LN-
ER+
NA
G2
2
T1c
4945
4952
1
0
alive
89.8
NA
NA
86-157_OXFA.CEL.gz
0
2
2
Poor
0
4952
4952
GSM177975
JRH
4.42
Basal
IBE
FID
ICR4
194
VDXOXFU_194
DistantMetastasis
4.64
Recurred/Progressed
DistantMetastasis
46
LN-
ER-
NA
G3
2.1
T2
1693
1693
3
1
dead
66.6
NA
NA
85-194_OXFA.CEL.gz
1
2
2
Poor
1
2985
1693
GSM177976
JRH
3.2
LumA
IBD
WID
ICR1
220
VDXOXFU_220
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
47
LN-
ER-
NA
G2
1
T1b
3725
4603
1
0
alive
91.6
NA
NA
87-220_OXFA.CEL.gz
1
1
2
Poor
0
4603
4603
GSM177977
JRH
4.2
Her2
IBE
WID
ICR3
245
VDXOXFU_245
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
54
LN-
ER-
NA
G3
1
T1b
4857
4857
1
0
alive
85.7
NA
NA
102-245_OXFA.CEL.gz
1
2
2
Poor
0
4857
4857
GSM177978
JRH
4.44
ClaudinLow
IBD
FID
ICR4
316
VDXOXFU_316
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
47
LN-
ER-
NA
G3
2.2
T2
4681
4681
1
0
alive
66.4
NA
NA
105-316_OXFA.CEL.gz
1
2
2
Poor
0
4681
4681
GSM177979
JRH
5
Basal
IBE
FID
ICR4
320
VDXOXFU_320
DistantMetastasis
8.12
Recurred/Progressed
DistantMetastasis
39
LN-
ER-
NA
G3
5
T2
2561
2965
1
1
dead
63.7
NA
NA
96-320_OXFA.CEL.gz
1
2
2
Good
0
2965
2965
GSM177980
JRH
4.6
Basal
IBE
PID
ICR2
360
VDXOXFU_360
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
32
LN-
ER-
NA
G3
3
T2
4596
4596
1
0
alive
68.2
NA
NA
98-360_OXFA.CEL.gz
1
2
2
Poor
0
4596
4596
GSM177981
JRH
4.5
Her2
IBE
PID
ICR2
366
VDXOXFU_366
DistantMetastasis
3.05
Recurred/Progressed
DistantMetastasis
57
LN-
ER-
NA
G3
2.5
T2
1038
1112
1
1
dead
62.7
NA
NA
75-366_OXFA.CEL.gz
1
2
2
Poor
1
1205
1112
GSM177982
JRH
3.76
Normal
IBE
NA
ICR3
513
VDXOXFU_513
DistantMetastasis
5.25
Recurred/Progressed
DistantMetastasis
47
LN-
ER-
NA
G2
3.8
T2
1141
1918
1
0
dead
64.5
NA
NA
79-513_OXFA.CEL.gz
1
2
2
Poor
0
1918
1918
GSM177983
JRH
3.36
LumB
IBE
PID
ICR1
530
VDXOXFU_530
DistantMetastasis
4.74
Recurred/Progressed
DistantMetastasis
54
LN-
ER+
NA
G2
1.8
T1c
996
1731
1
0
dead
85.7
NA
NA
89-530_OXFA.CEL.gz
1
2
2
Poor
1
2111
1731
GSM177984
JRH
2.36
LumA
IBD
PID
ICR1
544
VDXOXFU_544
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
54
LN-
ER+
NA
G1
1.8
T1c
4327
4327
1
0
alive
90.3
NA
NA
95-544_OXFA.CEL.gz
0
1
1
Poor
0
4327
4327
GSM177985
JRH
4.8
Basal
IBE
FID
ICR4
547
VDXOXFU_547
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
45
LN-
ER-
NA
G3
4
T2
4352
4352
1
0
alive
62.9
NA
NA
80-547_OXFA.CEL.gz
1
2
2
Poor
0
4352
4352
GSM177986
JRH
4.44
Her2
IBE
FID
ICR4
662
VDXOXFU_662
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
43
LN-
ER+
NA
G3
2.2
T2
2083
4181
1
0
alive
74
1
NA
100-662_OXFA.CEL.gz
1
2
2
Poor
0
4181
4181
GSM177987
JRH
2.2
LumA
IBD
PID
ICR1
869
VDXOXFU_869
DistantMetastasisFree
8.73
DiseaseFree
DistantMetastasisFree
48
LN-
ER+
NA
G1
1
T1b
3188
3188
7
0
alive
95.1
NA
NA
83-869_OXFA.CEL.gz
0
1
1
Good
0
3188
3188
GSM177988
JRH
4.4
ClaudinLow
IBD
FID
ICR3
1006
VDXOXFU_1006
DistantMetastasisFree
7.32
DiseaseFree
DistantMetastasisFree
43
LN-
ER+
NA
G3
2
T1c
2672
2672
1
0
alive
84.8
NA
NA
99-1006_OXFA.CEL.gz
1
2
2
Good
0
2672
2672
GSM177989
JRH
3.4
LumA
IBD
PID
ICR1
1065
VDXOXFU_1065
DistantMetastasis
2
Recurred/Progressed
DistantMetastasis
43
LN-
ER+
NA
G2
2
T1c
730
730
1
0
dead
89.6
NA
NA
103-1065_OXFA.CEL.gz
0
2
2
Poor
1
794
730
GSM177990
JRH
2.16
LumA
IBD
PID
ICR2
1183
VDXOXFU_1183
DistantMetastasisFree
4.36
DiseaseFree
DistantMetastasisFree
50
LN-
ER+
NA
G1
0.8
T1b
1591
1591
1
0
alive
94.3
1
NA
97-1183_OXFA.CEL.gz
0
1
1
Poor
0
1591
1591
GSM177991
JRH
2.16
Normal
IBE
NA
ICR1
1210
VDXOXFU_1210
DistantMetastasisFree
5.26
DiseaseFree
DistantMetastasisFree
43
LN-
ER+
NA
G1
0.8
T1b
1920
1920
1
0
alive
96.5
NA
NA
94-1210_OXFA.CEL.gz
0
1
1
Good
0
1920
1920
GSM177992
JRH
3.26
LumA
IBD
PID
ICR1
1328
VDXOXFU_1328
DistantMetastasisFree
7.25
DiseaseFree
DistantMetastasisFree
49
LN-
ER+
NA
G2
1.3
T1c
2647
2647
2
0
alive
88
NA
NA
84-1328_OXFA.CEL.gz
0
1
2
Poor
0
2647
2647
GSM177993
JRH
3.4
Basal
IBE
PID
ICR2
1373
VDXOXFU_1373
DistantMetastasis
0.74
Recurred/Progressed
DistantMetastasis
38
LN-
ER-
NA
G2
2
T1c
269
269
1
0
dead
84.5
3
NA
91-1373_OXFA.CEL.gz
1
2
2
Poor
1
413
269
GSM177994
JRH
3.18
ClaudinLow
IBD
PID
ICR2
1415
VDXOXFU_1415
DistantMetastasisFree
3.53
DiseaseFree
DistantMetastasisFree
47
LN-
ER-
NA
G2
0.9
T1b
1290
1290
2
0
alive
91.6
NA
NA
82-1415_OXFA.CEL.gz
1
1
2
Poor
0
1290
1290
GSM177995
KAR
3.2
LumA
IBD
PID
ICR1
121
VDXKIU_121
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
54
LN-
ER+
NA
G2
1
T1b
4568
4568
1
1
alive
90.3
NA
NA
245_-121_KIA.CEL.gz
0
1
2
Poor
0
4568
4568
GSM177996
KAR
2.38
LumA
IBD
WID
ICR2
205
VDXKIU_205
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
52
LN-
ER+
NA
G1
1.9
T1c
4537
4537
1
0
alive
91.5
NA
NA
238-205_KIA.CEL.gz
0
1
1
Good
0
4537
4537
GSM177997
KAR
3.28
LumB
IBD
FID
ICR3
386
VDXKIU_386
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
51
LN-
ER+
NA
G2
1.4
T1c
5035
5035
1
0
alive
87.2
NA
NA
147-386_KIA.CEL.gz
1
1
2
Poor
0
5035
5035
GSM177998
KAR
3.18
LumA
IBD
PID
ICR2
440
VDXKIU_440
DistantMetastasis
7.13
Recurred/Progressed
DistantMetastasis
50
LN-
ER+
NA
G2
0.9
T1b
1465
2604
1
0
dead
92.4
NA
NA
201-440_KIA.CEL.gz
0
1
2
Poor
1
3207
2604
GSM177999
KAR
3.8
Basal
IBE
PID
ICR1
1000
VDXKIU_1000
DistantMetastasis
1.08
Recurred/Progressed
DistantMetastasis
43
LN-
ER-
NA
G2
4
T2
394
394
1
1
dead
65.3
NA
NA
186-1000_KIA.CEL.gz
1
2
2
Poor
1
491
394
GSM178000
KAR
3.18
NA
IBE
NA
ICR1
1246
VDXKIU_1246
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasis
24
LN-
ER+
NA
G2
0.9
T1b
3512
6777
1
1
alive
95.4
NA
NA
212-1246_KIA.CEL.gz
0
1
2
Poor
0
8251
6777
GSM178001
KAR
4.28
Basal
IBE
PID
ICR2
1500
VDXKIU_15E2
DistantMetastasisFree
6.98
DiseaseFree
DistantMetastasisFree
40
LN-
ER+
NA
G3
1.4
T1c
2549
2549
1
0
alive
85.2
NA
NA
145-15E2_KIA.CEL.gz
1
2
2
Poor
0
2549
2549
GSM178002
KAR
3.2
LumA
IBD
FID
ICR3
1608
VDXKIU_1608
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
56
LN-
ER+
NA
G2
1
T1b
4085
4085
1
1
alive
89
NA
NA
134-1608_KIA.CEL.gz
0
1
2
Poor
0
4085
4085
GSM178003
KAR
4.4
Basal
IBE
FID
ICR3
1708
VDXKIU_1708
DistantMetastasis
7.92
Recurred/Progressed
DistantMetastasis
43
LN-
ER-
NA
G3
2
T1c
2892
2892
1
0
dead
80.8
NA
NA
196-1708_KIA.CEL.gz
1
2
2
Good
0
2892
2892
GSM178004
KAR
NA
Her2
IBD
WID
ICR3
2481
VDXKIU_2481
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
50
LN-
ER+
NA
NA
1.1
T1c
2441
5236
2
1
alive
87.6
NA
NA
138-2481_KIA.CEL.gz
1
NA
NA
Poor
0
5236
5236
GSM178005
KAR
2.2
LumB
IBE
WID
ICR1
2656
VDXKIU_2656
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
54
LN-
ER+
NA
G1
1
T1b
5406
5406
1
0
alive
92.2
NA
NA
126-2656_KIA.CEL.gz
0
1
1
Poor
0
5406
5406
GSM178006
KAR
4.44
Her2
IBE
PID
ICR2
2743
VDXKIU_2743
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
45
LN-
ER-
NA
G3
2.2
T2
4279
4279
1
1
alive
66.9
NA
NA
113-2743_KIA.CEL.gz
1
2
2
Poor
0
4279
4279
GSM178007
KAR
3.24
ClaudinLow
IBD
FID
ICR3
2889
VDXKIU_2889
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
43
LN-
ER+
NA
G2
1.2
T1c
1520
5359
1
0
alive
89.6
NA
NA
118-2889_KIA.CEL.gz
0
1
2
Good
0
5359
5359
GSM178008
KAR
2.4
LumA
IBD
PID
ICR1
2946
VDXKIU_2946
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
49
LN-
ER+
NA
G1
2
T1c
3964
3964
1
0
alive
92.8
NA
NA
142_-2946_KIA.CEL.gz
0
1
1
Poor
0
3964
3964
GSM178009
KAR
4.76
ClaudinLow
IBD
WID
ICR2
3367
VDXKIU_3367
DistantMetastasis
0.79
Recurred/Progressed
DistantMetastasis
53
LN-
ER-
NA
G3
3.8
T2
277
289
1
1
dead
60.8
NA
NA
190-3367_KIA.CEL.gz
1
2
2
Poor
1
642
289
GSM178010
KAR
4.22
Her2
IBE
WID
ICR3
15000000
VDXKIU_15E6
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
39
LN-
ER-
NA
G3
1.1
T1c
6298
6298
1
1
alive
81.4
NA
NA
131-15E6_KIA.CEL.gz
1
2
2
Poor
0
6298
6298
GSM178011
KAR
NA
Basal
IBE
FID
ICR4
150000000
VDXKIU_15E7
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
38
LN-
ER+
NA
NA
2.2
T2
4972
6399
6
0
alive
78.6
NA
NA
215-15E7_KIA.CEL.gz
1
NA
2
Poor
0
6399
6399
GSM178012
KAR
4.4
Basal
IBE
FID
ICR4
1500000000
VDXKIU_15E8
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
38
LN-
ER+
NA
G3
2
T1c
5683
5683
1
0
alive
85.5
NA
NA
243_-15E8_KIA.CEL.gz
1
2
2
Poor
0
5683
5683
GSM178013
KAR
4.24
ClaudinLow
IBD
PID
ICR1
101B88
VDXKIU_101B88
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
40
LN-
ER-
NA
G3
1.2
T1c
6240
6240
1
0
alive
81.3
NA
NA
229-101B88_KIA.CEL.gz
1
2
2
Poor
0
6240
6240
GSM178014
KAR
3.3
LumB
IBD
PID
ICR2
125B43
VDXKIU_125B43
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
38
LN-
ER+
NA
G2
1.5
T1c
6161
6161
3
0
alive
90.4
NA
NA
124-125B43_KIA.CEL.gz
0
1
2
Poor
0
6161
6161
GSM178015
KAR
3.34
LumA
IBD
PID
ICR1
136B04
VDXKIU_136B04
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
54
LN-
ER+
NA
G2
1.7
T1c
892
6132
1
0
alive
85.7
NA
NA
144-136B04_KIA.CEL.gz
1
2
2
Poor
0
6132
6132
GSM178016
KAR
3.42
LumA
IBD
WID
ICR3
144B49
VDXKIU_144B49
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasis
40
LN-
ER+
NA
G2
2.1
T2
4212
4212
1
1
dead
81.4
NA
NA
146-144B49_KIA.CEL.gz
1
2
2
Good
1
5337
4212
GSM178017
KAR
4.2
Her2
IBE
PID
ICR1
15C5
VDXKIU_15C5
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
56
LN-
ER-
NA
G3
1
T1b
4980
4980
NA
1
alive
84.4
NA
NA
120-15C5_KIA.CEL.gz
1
2
2
Good
0
4980
4980
GSM178018
KAR
3.4
LumB
IBD
PID
ICR1
15D6
VDXKIU_15D6
DistantMetastasis
4.67
Recurred/Progressed
DistantMetastasis
45
LN-
ER+
NA
G2
2
T1c
1703
1703
1
0
dead
89.2
NA
NA
129-15D6_KIA.CEL.gz
0
2
2
Poor
0
1703
1703
GSM178019
KAR
3.4
LumA
IBD
WID
ICR2
15D7
VDXKIU_15D7
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
46
LN-
ER+
NA
G2
2
T1c
5014
5014
2
0
alive
88.9
NA
NA
112-15D7_KIA.CEL.gz
0
2
2
Poor
0
5014
5014
GSM178020
KAR
4.32
Her2
IBE
WID
ICR3
15D9
VDXKIU_15D9
DistantMetastasis
2.41
Recurred/Progressed
DistantMetastasis
45
LN-
ER+
NA
G3
1.6
T1c
880
880
NA
0
dead
84.3
NA
NA
136-15D9_KIA.CEL.gz
1
2
2
Poor
1
1924
880
GSM178021
KAR
4.56
Basal
IBE
WID
ICR4
15H3
VDXKIU_15H3
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
33
LN-
ER-
NA
G3
2.8
T2
8711
8711
NA
1
alive
68.1
NA
NA
121-15H3_KIA.CEL.gz
1
2
2
Good
0
8711
8711
GSM178022
KAR
4.48
LumA
IBD
FID
ICR4
15H4
VDXKIU_15H4
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
37
LN-
ER-
NA
G3
2.4
T2
4672
4672
1
0
alive
67.9
NA
NA
116-15H4_KIA.CEL.gz
1
2
2
Poor
0
4672
4672
GSM178023
KAR
4.5
Basal
IBE
WID
ICR4
16B4
VDXKIU_16B4
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
42
LN-
ER-
NA
G3
2.5
T2
6943
6943
1
1
alive
67.3
NA
NA
111-16B4_KIA.CEL.gz
1
2
2
Poor
0
6943
6943
GSM178024
KAR
4.22
Normal
IBE
NA
ICR1
16C8
VDXKIU_16C8
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
47
LN-
ER+
NA
G3
1.1
T1c
6135
6135
1
1
alive
83.8
NA
NA
122-16C8_KIA.CEL.gz
1
2
2
Good
0
6135
6135
GSM178025
KAR
3.4
LumB
IBE
PID
ICR2
16G1
VDXKIU_16G1
DistantMetastasis
2.21
Recurred/Progressed
DistantMetastasis
43
LN-
ER+
NA
G2
2
T1c
805
805
1
1
dead
89.6
NA
NA
109-16G1_KIA.CEL.gz
0
2
2
Poor
1
1803
805
GSM178026
KAR
4.32
LumB
IBD
PID
ICR1
197B95
VDXKIU_197B95
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
44
LN-
ER+
NA
G3
1.6
T1c
5917
5917
1
0
alive
84.6
NA
NA
128-197B95_KIA.CEL.gz
1
2
2
Poor
0
5917
5917
GSM178027
KAR
3.46
Normal
IBE
NA
ICR4
199B55
VDXKIU_199B55
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
54
LN-
ER+
NA
G2
2.3
T2
5909
5909
1
1
alive
77.1
NA
NA
110-199B55_KIA.CEL.gz
1
2
2
Good
0
5909
5909
GSM178028
KAR
3.36
Basal
IBE
PID
ICR3
219C42
VDXKIU_219C42
DistantMetastasis
6.02
Recurred/Progressed
DistantMetastasis
51
LN-
ER-
NA
G2
1.8
T1c
2196
2196
1
0
dead
81.4
NA
NA
125-219C42_KIA.CEL.gz
1
2
2
Poor
0
2196
2196
GSM178029
KAR
3.4
LumA
IBD
PID
ICR2
220C70
VDXKIU_220C70
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
42
LN-
ER+
NA
G2
2
T1c
5860
5860
3
0
alive
89.8
NA
NA
127-220C70_KIA.CEL.gz
0
2
2
Poor
0
5860
5860
GSM178030
KAR
3.44
LumA
IBD
PID
ICR2
231C80
VDXKIU_231C80
DistantMetastasis
6.44
Recurred/Progressed
DistantMetastasis
56
LN-
ER+
NA
G2
2.2
T2
2349
2349
1
0
dead
76.1
NA
NA
115-231C80_KIA.CEL.gz
1
2
2
Good
1
3650
2349
GSM178031
KAR
3.5
LumA
IBD
PID
ICR1
247C76
VDXKIU_247C76
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
56
LN-
ER+
NA
G2
2.5
T2
5779
5779
1
0
alive
76.1
NA
NA
133-247C76_KIA.CEL.gz
1
2
2
Poor
0
5779
5779
GSM178032
KAR
4.46
LumA
IBD
PID
ICR1
248C91
VDXKIU_248C91
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
58
LN-
ER+
NA
G3
2.3
T2
5779
5779
3
0
alive
68.4
NA
NA
119-248C91_KIA.CEL.gz
1
2
2
Good
0
5779
5779
GSM178033
KAR
3.44
LumA
IBD
PID
ICR1
266C51
VDXKIU_266C51
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
58
LN-
ER+
NA
G2
2.2
T2
5723
5723
3
0
alive
74.8
NA
NA
205-266C51_KIA.CEL.gz
1
2
2
Good
0
5723
5723
GSM178034
KAR
3.3
ClaudinLow
IBD
PID
ICR4
268C87
VDXKIU_268C87
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
32
LN-
ER+
NA
G2
1.5
T1c
5714
5714
3
0
alive
87
NA
NA
117-268C87_KIA.CEL.gz
1
1
2
Good
0
5714
5714
GSM178035
KAR
4.38
Basal
IBE
PID
ICR2
279C61
VDXKIU_279C61
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
50
LN-
ER+
NA
G3
1.9
T1c
5653
5653
1
1
alive
82.8
NA
NA
132-279C61_KIA.CEL.gz
1
2
2
Poor
0
5653
5653
GSM178036
KAR
4.26
LumA
IBD
WID
ICR2
27B8
VDXKIU_27B8
DistantMetastasis
0.34
Recurred/Progressed
DistantMetastasis
49
LN-
ER-
NA
G3
1.3
T1c
125
125
1
1
dead
79.3
NA
NA
139-27B8_KIA.CEL.gz
1
2
2
Poor
1
146
125
GSM178037
KAR
2.38
LumA
IBD
WID
ICR4
27C4
VDXKIU_27C4
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
47
LN-
ER+
NA
G1
1.9
T1c
5678
5678
1
0
alive
93.4
NA
NA
235-27C4_KIA.CEL.gz
0
1
1
Poor
0
5678
5678
GSM178038
KAR
3.44
LumB
IBE
PID
ICR2
27D5
VDXKIU_27D5
DistantMetastasis
4.77
Recurred/Progressed
DistantMetastasis
56
LN-
ER+
NA
G2
2.2
T2
1742
1742
1
1
dead
76.1
NA
NA
143-27D5_KIA.CEL.gz
1
2
2
Poor
1
2697
1742
GSM178039
KAR
2.2
LumA
IBD
PID
ICR1
282C51
VDXKIU_282C51
DistantMetastasis
9.9
Recurred/Progressed
DistantMetastasis
55
LN-
ER+
NA
G1
1
T1b
865
3614
7
0
dead
91.5
NA
NA
141-282C51_KIA.CEL.gz
0
1
1
Good
0
3614
3614
GSM178040
KAR
3.36
LumA
IBD
WID
ICR2
284C63
VDXKIU_284C63
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
48
LN-
ER+
NA
G2
1.8
T1c
5602
5602
1
0
alive
88.3
NA
NA
184-284C63_KIA.CEL.gz
0
2
2
Poor
0
5602
5602
GSM178041
KAR
3.18
LumA
IBD
WID
ICR2
28C76
VDXKIU_28C76
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
56
LN-
ER+
NA
G2
0.9
T1b
5768
5768
NA
0
alive
89
NA
NA
114-28C76_KIA.CEL.gz
0
1
2
Good
0
5768
5768
GSM178042
KAR
3.4
LumA
IBD
WID
ICR2
292C66
VDXKIU_292C66
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
51
LN-
ER+
NA
G2
2
T1c
5684
5684
3
0
alive
87.2
NA
NA
137-292C66_KIA.CEL.gz
1
2
2
Poor
0
5684
5684
GSM178043
KAR
4.24
LumA
IBD
PID
ICR2
309C49
VDXKIU_309C49
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
44
LN-
ER+
NA
G3
1.2
T1c
5530
5530
3
0
alive
84.6
NA
NA
181-309C49_KIA.CEL.gz
1
2
2
Good
0
5530
5530
GSM178044
KAR
3.24
LumA
IBD
PID
ICR3
43C47
VDXKIU_43C47
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
46
LN-
ER-
NA
G2
1.2
T1c
232
5551
1
0
alive
83.1
NA
NA
182-43C47_KIA.CEL.gz
1
1
2
Poor
0
5551
5551
GSM178045
KAR
2.24
ClaudinLow
IBD
FID
ICR4
87A79
VDXKIU_87A79
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
36
LN-
ER+
NA
G1
1.2
T1c
6352
6352
3
1
alive
95.5
NA
NA
237-87A79_KIA.CEL.gz
0
1
1
Poor
0
6352
6352
GSM178046
RH
3.26
LumB
IBD
WID
ICR2
302
VDXRHU_302
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
44
LN-
ER+
NA
G2
1.3
T1c
722
6295
1
0
alive
89.4
0
NA
155-302_RHA.CEL.gz
0
1
2
Poor
0
6295
6295
GSM178047
RH
3.44
LumA
IBD
PID
ICR1
317
VDXRHU_317
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasis
41
LN-
ER+
NA
G2
2.2
T2
6590
7185
1
0
alive
81.2
0
NA
163-317_RHA.CEL.gz
1
2
2
Poor
1
7260
7185
GSM178048
RH
3.6
LumB
IBD
PID
ICR1
329
VDXRHU_329
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
60
LN-
ER+
NA
G2
3
T2
6281
6281
4
1
alive
73.4
0
NA
159-329_RHA.CEL.gz
1
2
2
Poor
0
6281
6281
GSM178049
RH
3.6
LumA
IBD
PID
ICR2
410
VDXRHU_410
DistantMetastasis
9.08
Recurred/Progressed
DistantMetastasis
59
LN-
ER+
NA
G2
3
T2
3313
3313
1
1
dead
74.2
0
NA
149-410_RHA.CEL.gz
1
2
2
Poor
1
4594
3313
GSM178050
RH
4.54
Her2
IBE
WID
ICR3
535
VDXRHU_535
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
48
LN-
ER-
NA
G3
2.7
T2
6003
6003
1
0
alive
66.2
0
NA
171-535_RHA.CEL.gz
1
2
2
Poor
0
6003
6003
GSM178051
RH
3.6
Normal
IBE
NA
ICR2
1207
VDXRHU_1207
DistantMetastasis
8.14
Recurred/Progressed
DistantMetastasis
53
LN-
ER+
NA
G2
3
T2
966
2972
1
1
dead
77.7
0
NA
152-1207_RHA.CEL.gz
1
2
2
Poor
0
2972
2972
GSM178052
RH
4.8
Her2
IBE
PID
ICR1
1246
VDXRHU_1246
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
43
LN-
ER-
NA
G3
4
T2
6232
6232
1
0
alive
63.3
0
NA
161-1246_RHA.CEL.gz
1
2
2
Good
1
6232
6232
GSM178053
RH
3.3
NA
IBE
NA
ICR3
1315
VDXRHU_1315
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
33
LN-
ER+
NA
G2
1.5
T1c
1857
9108
1
0
alive
86.9
0
NA
172-1315_RHA.CEL.gz
1
1
2
Poor
0
9108
9108
GSM178054
RH
2.52
LumA
IBD
FID
ICR2
1472
VDXRHU_1472
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasis
42
LN-
ER+
NA
G1
2.6
T2
4353
4353
2
0
dead
88.9
0
NA
162-1472_RHA.CEL.gz
0
1
2
Good
1
5445
4353
GSM178055
RH
4.8
ClaudinLow
IBD
PID
ICR2
1496
VDXRHU_1496
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
51
LN-
ER-
NA
G3
4
T2
3914
3914
1
1
alive
61.5
0
NA
177-1496_RHA.CEL.gz
1
2
2
Poor
0
3914
3914
GSM178056
RH
4.34
LumB
IBD
PID
ICR2
1522
VDXRHU_1522
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
31
LN-
ER+
NA
G3
1.7
T1c
5181
5181
1
0
alive
80.1
0
NA
156-1522_RHA.CEL.gz
1
2
2
Poor
0
5181
5181
GSM178057
RH
4.64
LumB
IBD
PID
ICR3
1526
VDXRHU_1526
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
60
LN-
ER+
NA
G3
3.2
T2
3855
3855
1
1
alive
59.9
0
NA
174-1526_RHA.CEL.gz
1
2
2
Good
0
3855
3855
GSM178058
RH
4.4
Her2
IBE
WID
ICR3
1549
VDXRHU_1549
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
46
LN-
ER+
NA
G3
2
T1c
5156
5156
1
0
alive
84.1
0
NA
158-1549_RHA.CEL.gz
1
2
2
Poor
0
5156
5156
GSM178059
RH
4.42
ClaudinLow
IBD
WID
ICR3
1568
VDXRHU_1568
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
59
LN-
ER-
NA
G3
2.1
T2
4744
4744
1
0
alive
61.5
0
NA
167-1568_RHA.CEL.gz
1
2
2
Poor
0
4744
4744
GSM178060
RH
2.64
Her2
IBE
PID
ICR2
1720
VDXRHU_1720
DistantMetastasis
2.18
Recurred/Progressed
DistantMetastasis
24
LN-
ER+
NA
G1
3.2
T2
794
794
1
0
dead
79.5
1
NA
165-1720_RHA.CEL.gz
1
1
2
Poor
1
1308
794
GSM178061
RH
3.6
LumA
IBD
FID
ICR3
1721
VDXRHU_1721
DistantMetastasis
4.38
Recurred/Progressed
DistantMetastasis
54
LN-
ER+
NA
G2
3
T2
1598
1598
0
1
dead
77.1
1
NA
221-1721_RHA.CEL.gz
1
2
2
Poor
1
1864
1598
GSM178062
RH
3.16
ClaudinLow
IBD
WID
ICR2
1745
VDXRHU_1745
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
55
LN-
ER+
NA
G2
0.8
T1b
5038
5038
1
0
alive
89.7
0
NA
170-1745_RHA.CEL.gz
0
1
2
Poor
0
5038
5038
GSM178063
RH
4.42
Her2
IBE
FID
ICR3
1767
VDXRHU_1767
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
41
LN-
ER-
NA
G3
2.1
T2
4874
4874
1
0
alive
67.5
1
NA
223-1767_RHA.CEL.gz
1
2
2
Poor
0
4874
4874
GSM178064
RH
4.5
LumB
IBE
PID
ICR2
1771
VDXRHU_1771
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
42
LN-
ER+
NA
G3
2.5
T2
4555
4555
1
0
alive
74.2
0
NA
226-1771_RHA.CEL.gz
1
2
2
Poor
0
4555
4555
GSM178065
RH
4.5
Her2
IBE
FID
ICR3
1917
VDXRHU_1917
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
47
LN-
ER-
NA
G3
2.5
T2
4487
4487
1
1
alive
66.4
0
NA
160-1917_RHA.CEL.gz
1
2
2
Poor
0
4487
4487
GSM178066
RH
4.44
Her2
IBE
FID
ICR4
1919
VDXRHU_1919
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
53
LN-
ER-
NA
G3
2.2
T2
4297
4297
1
0
alive
64.5
0
NA
168-1919_RHA.CEL.gz
1
2
2
Good
0
4297
4297
GSM178067
RH
3.48
LumA
IBD
WID
ICR2
1959
VDXRHU_1959
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
50
LN-
ER+
NA
G2
2.4
T2
4866
4866
2
1
alive
79
0
NA
216-1959_RHA.CEL.gz
1
2
2
Poor
0
4866
4866
GSM178068
RH
4.44
LumB
IBE
WID
ICR3
1970
VDXRHU_1970
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
44
LN-
ER+
NA
G3
2.2
T2
4178
4178
1
0
alive
73.8
0
NA
151-1970_RHA.CEL.gz
1
2
2
Poor
0
4178
4178
GSM178069
RH
2.3
LumB
IBE
FID
ICR4
2039
VDXRHU_2039
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasis
48
LN-
ER-
NA
G1
1.5
T1c
2674
4618
9
0
dead
90.3
0
1
173-2039_RHA.CEL.gz
1
1
2
Poor
1
6011
4618
GSM178070
RH
3.6
LumA
IBD
PID
ICR2
2248
VDXRHU_2248
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
49
LN-
ER+
NA
G2
3
T2
2541
4052
1
0
alive
79.3
0
NA
150-2248_RHA.CEL.gz
1
2
2
Good
0
4052
4052
GSM178071
RH
3.5
LumA
IBD
FID
ICR3
2320
VDXRHU_2320
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
43
LN-
ER+
NA
G2
2.5
T2
1432
3782
1
0
alive
80.8
0
NA
191-2320_RHA.CEL.gz
1
2
2
Poor
0
3782
3782
GSM178072
RH
2.4
ClaudinLow
IBD
PID
ICR2
2393
VDXRHU_2393
DistantMetastasisFree
9.57
DiseaseFree
DistantMetastasisFree
45
LN-
ER+
NA
G1
2
T1c
3492
3492
1
0
alive
94
0
NA
148-2393_RHA.CEL.gz
0
1
1
Poor
0
3492
3492
GSM178073
RH
4.28
Her2
IBE
WID
ICR3
2587
VDXRHU_2587
DistantMetastasisFree
7.02
DiseaseFree
DistantMetastasisFree
53
LN-
ER-
NA
G3
1.4
T1c
2561
2561
1
1
alive
77.7
0
NA
157-2587_RHA.CEL.gz
1
2
2
Good
0
2561
2561
GSM178074
RH
4.84
LumB
IBD
PID
ICR1
3642
VDXRHU_3642
DistantMetastasis
6.72
Recurred/Progressed
DistantMetastasis
40
LN-
ER+
NA
G3
4.2
T2
2454
2454
4
0
dead
66.6
0
NA
194-3642_RHA.CEL.gz
1
2
2
Poor
1
5284
2454
GSM178075
RH
4.64
Basal
IBE
FID
ICR4
4188
VDXRHU_4188
DistantMetastasisFree
7.89
DiseaseFree
DistantMetastasisFree
48
LN-
ER-
NA
G3
3.2
T2
2879
2879
1
0
alive
62.3
0
NA
176-4188_RHA.CEL.gz
1
2
2
Good
0
2879
2879
GSM178076
RH
3.3
ClaudinLow
IBD
FID
ICR3
5223
VDXRHU_5223
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
56
LN-
ER+
NA
G2
1.5
T1c
5137
5137
1
1
alive
84.4
0
NA
175-5223_RHA.CEL.gz
1
1
2
Poor
0
5137
5137
GSM178077
RH
3.34
LumA
IBD
WID
ICR2
5226
VDXRHU_5226
DistantMetastasisFree
10
Recurred/Progressed
DistantMetastasisFree
45
LN-
ER+
NA
G2
1.7
T1c
6961
7023
2
0
alive
89.2
0
NA
198-5226_RHA.CEL.gz
0
2
2
Poor
0
7023
7023
GSM178078
RH
4.44
Basal
IBE
PID
ICR3
5228
VDXRHU_5228
DistantMetastasisFree
10
DiseaseFree
DistantMetastasisFree
39
LN-
ER-
NA
G3
2.2
T2
5673
5673
1
0
alive
67.7
0
NA
164-5228_RHA.CEL.gz
1
2
2
Poor
0
5673
5673
GSM178079
RH
4.64
Basal
IBE
PID
ICR3
5232
VDXRHU_5232
DistantMetastasis
1.11
Recurred/Progressed
DistantMetastasis
46
LN-
ER-
NA
G3
3.2
T2
404
404
1
0
dead
62.7
0
NA
236-5232_RHA.CEL.gz
0
2
2
Poor
1
1246
404
GSM178080
RH
2.5
LumB
IBD
PID
ICR2
5235
VDXRHU_5235
DistantMetastasisFree
6.1
DiseaseFree
DistantMetastasisFree
47
LN-
ER+
NA
G1
2.5
T2
2225
2225
1
0
alive
87.6
1
NA
195-5235_RHA.CEL.gz
1
1
2
Poor
0
2225
2225
GSM178081
RH
3.24
Normal
IBE
NA
ICR4
5236
VDXRHU_5236
DistantMetastasisFree
7.46
DiseaseFree
DistantMetastasisFree
43
LN-
ER+
NA
G2
1.2
T1c
2722
2722
1
0
alive
89.6
0
NA
204-5236_RHA.CEL.gz
0
1
2
Good
0
2722
2722
GSM178082
RH
4.5
ClaudinLow
IBD
WID
ICR3
5240
VDXRHU_5240
DistantMetastasisFree
4.88
Recurred/Progressed
DistantMetastasisFree
39
LN-
ER-
NA
G3
2.5
T2
1345
1781
9
0
alive
67.7
0
NA
154-5240_RHA.CEL.gz
1
2
2
Poor
0
1781
1781

Group Sets View in Gene Expression Browser

Name  
All Samples Default  View
ER Status   View
Histology Differentiation Grade   View
Immune Benefit Status   View
Immunological Constant of Rejection   View
Lymph Node Status   View
Molecular Subtype   View
Pathology T Stage   View
In order to make new Group Sets or change settings, please log in.

Module Analysis

Group Set  
All Samples
ER Status
Histology Differentiation Grade
Immune Benefit Status
Immunological Constant of Rejection
Lymph Node Status
Molecular Subtype
Pathology T Stage
Your bug report has been sent!